Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Biote Q4 2024 GAAP EPS $0.10, Inline, Sales $49.834M Miss $51.245M Estimate

Author: Benzinga Newsdesk | March 13, 2025 10:47am
Biote (NASDAQ:BTMD) reported quarterly earnings of $0.10 per share which met the analyst consensus estimate. This is a 44.44 percent decrease over earnings of $0.18 per share from the same period last year. The company reported quarterly sales of $49.834 million which missed the analyst consensus estimate of $51.245 million by 2.75 percent. This is a 9.04 percent increase over sales of $45.703 million the same period last year.

Posted In: BTMD


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist